ADMA Biologics
ADMA
ADMA
95 hedge funds and large institutions have $143M invested in ADMA Biologics in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 27 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.4% more ownership
Funds ownership: 56.11% → 56.51% (+0.4%)
13% less call options, than puts
Call options by funds: $1.42M | Put options by funds: $1.63M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
95
Holding in Top 10
–
Calls
$1.42M
Puts
$1.63M
Top Buyers
| 1 | +$1.35M | |
| 2 | +$1.24M | |
| 3 | +$1.21M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$859K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$857K |
Top Sellers
| 1 | -$2.53M | |
| 2 | -$2.12M | |
| 3 | -$1.13M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$737K |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$735K |